Prenylated quinolinecarboxylic acid derivative prevents neuronal cell death through inhibition of MKK4
Sign Up to like & getrecommendations! Published in 2019 at "Biochemical Pharmacology"
DOI: 10.1016/j.bcp.2018.10.008
Abstract: &NA; The development of neuroprotective agents is necessary for the treatment of neurodegenerative diseases. Here, we report PQA‐11, a prenylated quinolinecarboxylic acid (PQA) derivative, as a potent neuroprotectant. PQA‐11 inhibits glutamate‐induced cell death and caspase‐3… read more here.
Keywords: prenylated quinolinecarboxylic; pqa; mkk4; cell death ... See more keywords
The Antidepressant-like Activity, Effects on Recognition Memory Deficits, Bioavailability, and Safety after Chronic Administration of New Dual-Acting Small Compounds Targeting Neuropsychiatric Symptoms in Dementia
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911452
Abstract: This study aimed to extend the body of preclinical research on prototype dual-acting compounds combining the pharmacophores relevant for inhibiting cyclic nucleotide phosphodiesterase 10 (PDE10A) and serotonin 5-HT1A/5-HT7 receptor (5-HT1AR/5-HT7R) activity into a single chemical… read more here.
Keywords: administration; antidepressant like; pqa; pqa az6 ... See more keywords